619,000 décèsLe nombre de décès dus au paludisme dans le monde était estimé à 619 000 en 2021.
Malipaludismeobserved 2021HAL · Unilimdocument of 214 observations
Gold tier: mechanically validated evidence, with its primary source.
1,197 evidence items · page 43 / 48
619,000 décèsLe nombre de décès dus au paludisme dans le monde était estimé à 619 000 en 2021.
Malipaludismeobserved 2021HAL · Unilimdocument of 214 observations
96.77 %P. falciparum was more frequent in symptomatic individuals (96.77%) compared to asymptomatic individuals (93.24%).
Malipaludismepublished 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 16 observations
305 per_1000_person-yearsThere were 305 events of uncomplicated clinical malaria per 1000 person-years at risk in the chemoprevention-alone group.
Malipaludismepublished 2021The New England journal of medicineeurope_pmcdocument of 10 observations
25 %Pericopsis laxiflora était utilisé contre les douleurs musculaires avec une fréquence d'utilisation de 25 %.
Malidouleurs musculairesHAL · Unilimdocument of 20 observations
46 %46% of the 71 initial non-carriers had gametocytes detected by day 7 in the 2010–2011 study.
Malipaludismeobserved 2010-2011published 2016Parasite (Paris, France)europe_pmcdocument of 5 observationsDOI 10.1051/parasite/2016003
58 %Dans l'étude ECoVAM menée d'octobre 2021 à janvier 2022 au Mali, 58 % des patients recrutés (1 405 sur 2 347) présentaient des symptômes cliniques évocateurs de COVID-19.
MaliCOVID-19observed octobre 2021 à janvier 2022HAL · Unilimdocument of 36 observations
In Mali, a study by Druetz et al. evaluated the direct and indirect effects of SMC in a routine context and showed a significant reduction in malaria incidence among children exposed to SMC, including those older than 5 years.
MalipaludismeHAL · Unilimdocument of 147 observations
2.5 %Iron deficiency was found in 19 SCD patients (2.5%) in a cross-sectional study of 757 SCD patients in Bamako, Mali.
Malidrépanocytosepublished 2024Hemoglobineurope_pmcdocument of 9 observations
11 daysAt least 11–14 days after the onset of the disease is reported to be necessary to observe an average seroconversion rate of approximately 90%–100% for antibodies (IgM or IgG) against the SARS-CoV-2 S and N proteins.
MaliCOVID-19HAL · Unilimdocument of 67 observations
Children under five were the most affected by the malaria outbreak in the Kidal region.
MalipaludismeHAL · Unilimdocument of 80 observations
57 %En Malaisie, le nombre de cas de P. knowlesi représentait 57 % des infections paludéennes en 2013.
Malipaludismeobserved 2013HAL · Unilimdocument of 214 observations
1,462 parasites/μLLa parasitémie moyenne de P. malariae était de 1462 parasites par μL de sang avec un écart type de 1051 parasites par μL.
MalipaludismeHAL · Unilimdocument of 214 observations
22,360 parasites/microlitreLa médiane du nombre de parasites de Plasmodium falciparum par microlitre chez les 95 patients du groupe Kollé est de 22 360 (IQR : 3 760–60 620).
MalipaludismeHAL · Unilimdocument of 62 observations
9 deathsThere were 9 declared deaths caused by COVID-19 compared to approximately 156 expected deaths in the urban commune of Tombouctou.
MaliCOVID-19HAL · Unilimdocument of 88 observations
0.32 %P. ovale prevalence was 0.32% in passive screening.
Malipaludismepublished 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 16 observations
0.12 proportionThe minor allele frequency of the A443T polymorphism in the study population sample was 0.12.
Malipaludismepublished 2018PloS oneeurope_pmcdocument of 6 observationsDOI 10.1371/journal.pone.0192850
60 %The frequency of the pfmdr1 86Y mutation in Plasmodium falciparum was 60% (6/10) after treatment.
Malipaludismepublished 2021The Journal of parasitologyeurope_pmcdocument of 8 observations
4 %Au Mali, P. malariae était responsable de 4 à 14 % des cas de paludisme.
MalipaludismeHAL · Unilimdocument of 214 observations
Anaemia was observed in most Plasmodium malariae infected participants, in both symptomatic and asymptomatic cases.
Malipaludismepublished 2025PLoS neglected tropical diseaseseurope_pmcdocument of 4 observations
81 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 81% showed a 2-fold increase in anti-CSP IgG antibody titres post-2020 as measured by GSK ELISA.
Burkina Faso · Malipaludismeobserved post-2020HAL · Unilimdocument of 105 observations
1.6 %In the SMC children, the prevalence of the Pfdhfr-dhps quintuple mutant genotype was 1.6% before SMC and increased to 7.1% after SMC.
Malipaludismepublished 2016PloS oneeurope_pmcdocument of 4 observations
20.3 %In the pre-COVID-19 sample group (N = 283), the prevalence of antibody responders against S was 20.3% among females.
MaliSARS-CoV-2 S proteinHAL · Unilimdocument of 67 observations
2.08 R0The estimated R0 of the COVID-19 infection in Tombouctou was 2.08 [1.46–2.93].
MaliCOVID-19HAL · Unilimdocument of 88 observations
5.9 %Between July 2022 and October 2023, 588 out of 9941 patients with severe respiratory illness tested positive for SARS-CoV-2, corresponding to a positivity rate of 5.9%.
Kenya · MaliCOVID-19observed July 2022 to October 2023published 2026VaccinePubMeddocument of 8 observations
16.88 μg/mlLe niveau moyen d'AGE était de 16,88 μg/ml chez les Dogon.
Malipaludismeobserved 2017HAL · Unilimdocument of 31 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.